MedPath

Erector spinae muscle plane block on both side of spine using ultrasound machine for postoperative pain control in patients undergoing laparoscopic gall bladder surgery.

Not yet recruiting
Conditions
Calculus of gallbladder without cholecystitis,
Registration Number
CTRI/2019/05/019184
Lead Sponsor
Department of Anaesthesiology
Brief Summary

Pain is the dominating complaint and the primary reason for prolonged convalescence after laparoscopic cholecystectomy1. It has been hypothesized that intense acute pain after laparoscopic cholecystectomy may predict development of chronic pain (e.g.  Post laparoscopic cholecystectomy syndrome)2. Erector spinae plane block is a novel thoracic myofascial plane block that was reported first in 2016.3 It is a simpler and safer alternative to thoracic paravertebral and epidural blockade because the sonographic target is easily visualized and the site of injection is distant to the neuraxis and any major vascular structures and provides more extensive cranio-caudal spread with a single injection without major complications4

**Objective :** To study and compare the analgesic efficacy of single shot bilateral erector spinae plane block in patients undergoing laparoscopic cholecystectomy.

**DESIGN** : Double blind , prospective, randomized controlled study

**Methodology** : A blinded anaesthetist 1 will explain about ESP block to patient and takes I/W consent in preoperative period and he will also collect the data later on.

On day of surgery anaesthetist 2 will prepare 2 syringes of 20ml 0.375% ropivacaine or normal saline as per computer generated random table and assign a number and accordingly group (1/2) to the patient.

A blinded anaesthetist 3 will give bilateral ESP block with 20 ml of drug each side under USG guidance after induction of anaesthesia.

Anaesthetist 1 will manage case as per protocol with 2mcg/kg fentanyl at induction, 1mcg/kg at port insertion.

Inj. Paracetamol 1gm iv pre-emptively

Fentanyl repeated after 1 hour henceforth 1mcg/kg if needed

Inj. Paracetamol 1 gm iv will be continued 8th hourly.

Rescue analgesic in postoperative period (when the VAS > 4) : Inj. Diclofenac 75mg iv

 **References :**

1. *Bisgaard T, Klarskov B, Rosenberg J, Kehlet H: Factors determining convalescence after uncomplicated laparoscopic cholecystectomy. Arch Surg 2001; 136:917–21*

2. *Bisgaard T, Rosenberg J, Kehlet H: From acute to chronic pain after laparoscopic cholecystectomy: A prospective follow-up analysis. Scand J Gastroenterol 2005; 40:1358–64*

3. *Forero M, Adhikary SD, Lopez H, et al. The erector spinae plane block: A novel analgesic technique in thoracic neuropathic pain. Reg Anesth Pain Med 2016;41:621–7*



4. *Forero M, Rajarathinam M, Adhikary S, et al. Continuous erector spinae plane block for rescue analgesia in thoracotomy after epidural failure: A case report. A A Case Rep 2017;8:254–6*

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
84
Inclusion Criteria

ASA I and II patients, Undergoing elective laparoscopic cholecystectomy under general anaesthesia.

Exclusion Criteria

Patients with contraindications for regional anesthesia, known allergy to local anesthetics, bleeding diathesis, use of anticoagulants or corticosteroids, psychiatric disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative pain using a visual analog scale (VAS) in both groups at rest and dynamic pain on coughing.0 (at arrival in postoperative ICU), 1, 6, 12, 24 hours
Secondary Outcome Measures
NameTimeMethod
Total need for rescue analgesic in postoperative period24 hrs postoperatively
Intraoperative total fentanyl consumptionAt the end of surgery
Time to ambulation of patientAt 6hrs, 12hrs, 18hrs or 24 hours.

Trial Locations

Locations (1)

Sanjay Gandhi Post Graduate Institute of Medical Sciences

🇮🇳

Lucknow, UTTAR PRADESH, India

Sanjay Gandhi Post Graduate Institute of Medical Sciences
🇮🇳Lucknow, UTTAR PRADESH, India
Ruchi Verma
Principal investigator
9415590425
ruchiv197@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.